Showing results (181-190 of 297) with videos related to

Sort By:
Pageof 30
Kidney International|March 27, 2026
Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentaryBrad H Rovin, Jonathan Barratt, H Terence Cook, et al.
Transplantation Proceedings|June 5, 2020
Determinants of Successful Use of Sirolimus in Renal Transplant PatientsMarcel G Naik, Jan Steffen Jürgensen, Wolfgang Arns, et al.
Annals of Vascular Surgery|February 11, 2010
Analysis of calcifications in patients with coral reef aortaGeorg Schlieper, Dirk Grotemeyer, Anke Aretz, et al.
Kidney International Reports|July 13, 2026
Characterization of Patient-Reported Loin Pain in IgANKristina L Newman, Jonathan Barratt, Justyna Szklarzewicz, et al.
The Journal of Pathology|November 30, 2012
Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanismsLuigi Villa, Peter Boor, Andrzej Konieczny, et al.
Hypertension (Dallas, Tex. : 1979)|September 23, 2009
Prenatal dexamethasone exposure does not alter blood pressure and nephron number in the young adult marmoset monkeyCarsten Paul Bramlage, Christina Schlumbohm, Christopher Robert Pryce, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 2012
Biological responses to PDGF-AA versus PDGF-CC in renal fibroblastsClaudia Seikrit, Corinna Henkel, Claudia R C van Roeyen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2021
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney diseaseAgnès Bénardeau, Antje Kahnert, Tibor Schomber, et al.
BMC Nephrology|May 10, 2022
Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort studyCédric Jäger, Susanne Stampf, Karen Molyneux, et al.
Pageof 30